Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Long intergenic non-protein coding RNA 1583 (LINC01583) is a member of the long intergenic non-coding RNA (lincRNA) family, a class of RNA molecules longer than 200 nucleotides that do not overlap protein-coding genes and are not translated into protein[1][3][5][9]. LincRNAs, including LINC01583, have been implicated in roles such as remodeling chromatin, regulating genome architecture, stabilizing RNA, and fine-tuning the expression of neighboring genes, often with tissue specificity[3][5][7][9]. While specific functional studies or therapeutic targeting data for LINC01583 itself are not currently available, lincRNAs as a broader class are increasingly recognized for their regulatory functions in gene expression and potential associations with disease states[3][5]. LINC01583 is not a canonical therapeutic target such as a receptor, enzyme, or transporter, and no known drugs are reported to interact with it[1][3][5].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Long intergenic non-protein coding RNA 1583 (LINC01583).